IP Library Granted Patent US 7,875,762
Granted Patent B2
US 7,875,762 · App. 11/337,361 · Granted Jan 25, 2011

Method of producing an exogenous protein in the egg of a chicken

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,762
App. No.
11/337,361
Granted
Jan 25, 2011
Kind
B2
Abstract

This invention provides for proteins which are expressed in the avian oviduct, packaged into eggs laid by the avian and removed from the eggs.

Claims (14)

1. A method comprising introducing a transgene encoding an exogenous protein and a signal peptide into a chicken embryo; allowing the embryo to develop into a sexually mature male chicken; breeding the male chicken to a recipient female chicken; obtaining offspring from the recipient female which express the protein in tubular gland cells of the oviduct from which the protein is secreted; and recovering from an egg of an offspring a protein wherein the protein is exogenous to the egg and is encoded by the transgene.

2. The method of claim 1 wherein the transgene is contained between a 5 ′ LTR and 3 ′ LTR of a retroviral vector.

3. The method of claim 1 wherein the exogenous protein is selected from the group consisting of antitrypsin, antithrombin III, collagen, factors VIII, IX, X, fibrinogen, insulin, lactoferrin, protein C, tissue-type plasminogen activator, somatotrophin, cytokine, antibody, human growth hormone, immunotoxin and chymotrypsin.

4. The method of claim 1 wherein the exogenous protein is present in egg white of the egg.

5. The method of claim 1 wherein the transgene comprises a retroviral vector.

6. The method of claim 5 wherein the retroviral vector is an ALV,

7. A method comprising introducing a transgene encoding a pharmaceutical protein and a signal peptide into a chicken embryo; allowing the embryo to develop into a sexually mature male chicken; breeding the male chicken to a recipient female chicken; obtaining offspring from the recipient female which express the pharmaceutical protein in tubular gland cells of the oviduct from which the protein is secreted; and recovering a pharmaceutical protein from an egg of an offspring wherein the pharmaceutical protein is exogenous to the egg and is encoded by the transgene.

8. The method of claim 7 wherein the pharmaceutical protein is present in egg white of the egg.

9. A method comprising introducing a transgene encoding an exogenous cytokine and a signal peptide into a chicken embryo; allowing the embryo to develop into a sexually mature male chicken; breeding the male chicken to a recipient female chicken; obtaining offspring from the recipient female which express the protein in tubular gland cells of the oviduct from which the protein is secreted; and recovering from an egg of an offspring a cytokine.

10. The method of claim 9 wherein the cytokine is GM-CSF.

11. The method of claim 9 wherein the cytokine is G-CSF.

12. The method of claim 9 wherein the cytokine is erythropoietin.

13. The method of claim 9 wherein the cytokine is interferon.

14. The method of claim 9 comprising isolating the cytokine.

Assignments (3)
CHANGE OF NAME Recorded Jan 30, 2009
From: AVIGENICS, INC.
To: SYNAGEVA BIOPHARMA CORP.
Reel/Frame 022177/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2006
From: IVARIE, ROBERT D.; MORRIS, JULIE A.; LIU, GUODONG
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 017490/0326 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2006
From: HARVEY, ALEX J.; RAPP, JEFFREY C.
To: AVIGENICS, INC.
Reel/Frame 017505/0711 →